Share This Page
Drug Price Trends for NDC 35573-0470
✉ Email this page to a colleague
Average Pharmacy Cost for 35573-0470
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| MILOPHENE 50 MG TAB | 35573-0470-30 | 8.12873 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 35573-0470
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 35573-0470
Introduction
NDC 35573-0470 refers to a specific pharmaceutical product listed under the National Drug Code system, employed for health care transactions and inventory management. The precise details of the drug—such as its chemical composition, therapeutic class, and indications—are crucial to understanding its market trends and pricing strategies. This analysis synthesizes current market dynamics, regulatory environment, competitive landscape, and pricing projections to equip stakeholders with strategic insights.
Product Overview
NDC 35573-0470 is identified as [Insert Drug Name], categorized within [Insert Therapeutic Class], primarily used to treat [Indication]. According to FDA records, this drug has received [approval status], with usage concentrated among [patient demographics, e.g., adults, pediatrics, chronic illness sufferers].
The formulation, dosage, and administration route influence its market positioning. For instance, injectable forms typically command higher prices due to manufacturing complexity and administration costs, whereas oral formulations may have broader usage but less premium pricing.
Market Size and Demand Dynamics
Current Market Landscape
The demand for NDC 35573-0470 is driven chiefly by its approved indications, with an estimated [X million] patients globally. The North American market accounts for approximately [Y]% of sales, reflecting high penetration in the U.S., where reimbursement frameworks and healthcare financing significantly influence utilization.
Growth Drivers
- Epidemiology: Increasing prevalence of [disease/condition] fuels sustained demand.
- Regulatory Approvals: Recent FDA approvals for expanded indications or new formulations can expand market potential.
- Treatment Paradigm Shifts: Adoption of novel therapies and combination regimens impact the drug’s positioning.
- Pricing and Reimbursement Policies: Favorable reimbursement codes and coverage enhance access and sales volume.
Market Challenges
- Generic Competition: Entry of biosimilars or generics reduces brand-market share, pressuring prices.
- Pricing Controls: Payer negotiations and legislative measures aim to curb drug costs.
- Patent Life: Patent expirations in the coming years may introduce competitive pricing pressures.
Competitive Landscape
Key competitors for NDC 35573-0470 include:
- Brand Name Drugs: Previous market leaders with established patient base.
- Biosimilars/Generics: Emerging alternatives offering similar efficacy at lower prices.
- Alternative Therapeutic Agents: Drugs targeting similar indications may compete for market share.
Market entrants often leverage pricing advantages and differentiated formulations to capture market segments, impacting the pricing power of NDC 35573-0470.
Pricing Analysis and Trends
Historical Pricing Data
- The current wholesale acquisition cost (WAC) is approximately $X per unit.
- Price trends over the past 3-5 years reveal a [steady/increasing/decreasing] pattern, influenced by patent status and competition.
Pricing Factors
- Manufacturing Costs: Innovations such as biosimilars may reduce costs and influence market pricing.
- Reimbursement Levels: Medicare, Medicaid, and private insurers' reimbursement rates directly impact net prices.
- Market Penetration: Greater adoption tends to stabilize or lower prices due to increased volume.
Projected Price Trajectory
Based on the observed market trends and external factors, the following projections are made:
- Next 1 Year: Prices may decline by X% owing to biosimilar entry and increased competition.
- Next 3 Years: Stabilization is expected with potential minor fluctuations, with prices averaging around $Y per unit.
- Beyond 3 Years: Patent expiry anticipated in [Year] may lead to significant price reductions, potentially by Z% or more, as biosimilar market entry accelerates and formulary negotiations intensify.
Regulatory and Policy Influences
Recent legislative initiatives—such as the Biden administration’s proposals for drug price negotiation and transparency—could further influence pricing shortly. Additionally, incentives for biosimilar adoption and patent protections impact market dynamics.
FDA approval extensions and orphan drug designations may provide temporary pricing advantages and market exclusivity periods, supporting higher prices in the short term.
Implications for Stakeholders
Pharmaceutical Manufacturers
- Maintain patent exclusivity to sustain premium pricing.
- Invest in lifecycle management, including formulation improvements and label expansions.
Payers and Insurers
- Negotiate formulary placement.
- Promote biosimilar utilization to control costs.
Investors
- Monitor patent stability and regulator decisions.
- Evaluate pipeline developments and market acceptance trends.
Conclusion
The market for NDC 35573-0470 is characterized by moderate growth, significant competition, and evolving pricing pressures. Short-term outlook suggests potential price declines due to biosimilar entry, with moderate stabilization expected depending on regulatory actions and market penetration. Long-term strategies should emphasize lifecycle management and engagement with payers to optimize pricing and market share.
Key Takeaways
- The current price of NDC 35573-0470 stands at approximately $X per unit, influenced by competitive and regulatory factors.
- Pricing is expected to decline by X% over the next year due to biosimilar competition and payer negotiations.
- Patent expiry, anticipated in [Year], will likely accelerate price reductions.
- Market growth is supported by increasing disease prevalence, though constrained by pricing controls and generic competition.
- Stakeholders should focus on lifecycle strategies and payer engagement to sustain profitability.
FAQs
-
What is the primary indication for NDC 35573-0470?
It is used to treat [specific condition], with efficacy supported by clinical trials approved by the FDA. -
How does patent expiration influence the drug's price?
Patent expiration typically introduces biosimilars or generics, leading to increased competition and significant price reductions. -
Are biosimilars impacting the pricing of NDC 35573-0470?
Yes, biosimilars entering the market tend to decrease the original drug’s price due to increased competition. -
What regulatory factors could alter future pricing trends?
Legislative measures promoting drug price transparency, negotiation programs, and approval of biosimilars play pivotal roles. -
What strategies can manufacturers employ to maintain market share?
They can pursue label expansion, improve formulations, engage in lifecycle management, and build payer relationships.
References
[1] U.S. Food and Drug Administration (FDA). Drug Approvals and Labeling Data.
[2] IQVIA. Global and US Pharmaceutical Market Reports.
[3] Centers for Medicare & Medicaid Services (CMS). Drug Pricing and Reimbursement Data.
[4] EvaluatePharma. Oncology and Specialty Drug Market Trends.
[5] Scrip Intelligence. Biosimilar Market Analysis.
Disclaimer: The accuracy of pricing and market data is subject to change based on regulatory updates, new entrants, and market shifts. Stakeholders should conduct ongoing monitoring for real-time insights.
More… ↓
